Volume 30, Number 7—July 2024
Dispatch
Evidence of Orientia spp. Endemicity among Severe Infectious Disease Cohorts, Uganda
Table 1
Participant | Days after illness onset† |
Orientia spp.–positive titer‡ |
Spotted fever group titer |
Typhus group titer |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acute | Conv. | Fold change | Acute | Conv. | Fold change | Acute | Conv. | Fold change | Acute | Conv. | ||||
Mubende | ||||||||||||||
A |
7 |
34 |
4 |
256 |
1,024 |
1 |
32 |
32 |
1 |
32 |
32 |
|||
Fort Portal | ||||||||||||||
B | 2 | 32 | 8 | 64 | 512 | 1 | 32 | 32 | 1 | 32 | 32 | |||
C | 14 | 36 | 4 | 128 | 512 | 1 | 32 | 32 | 1 | 32 | 32 | |||
D | 1 | 38 | 4 | 128 | 512 | 1 | 32 | 32 | 1 | 32 | 32 |
*Conv., convalescent; IFA, immunofluorescent assay. †Sample collection after illness onset. ‡Karp strain IFA. Gilliam strain IFA seroconversion also observed in Fort Portal participant D (acute titers 1:512 and convalescent titers 1:2,048) but not among participants A-C.
1Members of the Acute Febrile Illness and Sepsis in Uganda study teams are listed at the end of this article.
Page created: May 10, 2024
Page updated: June 22, 2024
Page reviewed: June 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.